Sign in
4

Changes in Ownership

NeuroSense Therapeutics Ltd. Filed Acc 0001213900-26-038545

Chief Financial Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Eisenberg Or Chief Financial Officer 2026-03-26 Grant or award +200,000 1,254,050 D
Loading xslF345X06/ownership.xml…